SCHEMBL10016633

SCHEMBL10016633

CCCCCCC/C=C/C(=O)N(CC)CCCCCCC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ZDHHC20 Q5W0Z9 1/20 0.48
PPARG P37231 5/20 0.46
PPARA Q07869 5/20 0.46
EPHX2 P34913 1/20 0.45
TERT O14746 3/20 0.44
PTPN1 P18031 3/20 0.44
PPARD Q03181 3/20 0.44
CYP1A2 P05177 2/20 0.44
MAPT P10636 2/20 0.44
CYP2C19 P33261 2/20 0.44
BLM P54132 2/20 0.44
HSD17B10 Q99714 2/20 0.44
FABP4 P15090 2/20 0.44
FAAH O00519 2/20 0.44
KMT2A Q03164 2/20 0.44
GMNN O75496 1/20 0.44
USP2 O75604 1/20 0.44
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12924014 0.93 PPARG (0.46) PPARGPPARATERTPTPN1PPARD
SCHEMBL10016662 0.93 ZDHHC20 (0.50) ZDHHC20PPARGPPARAEPHX2TERT
SCHEMBL28066861 0.93 ZDHHC20 (0.50) ZDHHC20PPARGPPARAEPHX2TERT
SCHEMBL8036393 0.93 ZDHHC20 (0.50) ZDHHC20PPARGPPARAEPHX2TERT
SCHEMBL15205175 0.93 ZDHHC20 (0.50) ZDHHC20PPARGPPARAEPHX2TERT
SCHEMBL10016640 0.93 ZDHHC20 (0.50) ZDHHC20PPARGPPARAEPHX2TERT
SCHEMBL28066925 0.91 PPARG (0.50) PPARGPPARATERTPTPN1PPARD
SCHEMBL8594316 0.91 PPARG (0.50) PPARGPPARATERTPTPN1PPARD
SCHEMBL10016647 0.91 PPARG (0.50) PPARGPPARATERTPTPN1PPARD
SCHEMBL10016666 0.90 PPARG (0.44) PPARGPPARAEPHX2TERTPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2636666-B1 TRANS-2-DECENOIC ACID DERIVATIVE AND MEDICAMENT CONTAINING SAME NAGOYA INDUSTRIAL SCIENCE RES INSTITUTE (JP) 2018-01-10 EP disclosed
CN-103189350-B Trans-2-decenoic acid derivative and drug containing same NAGOYA INDUSTRIAL SCIENCE RESRARCH INSTITUTE (JP) 2016-04-27 CN disclosed
US-20150297562-A1 ANALGESIC NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2015-10-22 US disclosed
US-20150297562-A1 ANALGESIC NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2015-10-22 US disclosed
US-20150297562-A1 ANALGESIC NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2015-10-22 US disclosed
US-8987486-B2 Trans-2-decenoic acid derivative and pharmaceutical agent containing the same NAGOYA INDUSTRIAL SCIENCE RESEARCH INSTITUTE (JP) 2015-03-24 US disclosed
US-8987486-B2 Trans-2-decenoic acid derivative and pharmaceutical agent containing the same NAGOYA INDUSTRIAL SCIENCE RESEARCH INSTITUTE (JP) 2015-03-24 US disclosed
US-8987486-B2 Trans-2-decenoic acid derivative and pharmaceutical agent containing the same NAGOYA INDUSTRIAL SCIENCE RESEARCH INSTITUTE (JP) 2015-03-24 US disclosed
EP-2842553-A1 ANALGESIC Nippon Zoki Pharmaceutical Co., Ltd. (JP) 2015-03-04 EP disclosed
EP-2842553-A1 ANALGESIC Nippon Zoki Pharmaceutical Co., Ltd. (JP) 2015-03-04 EP disclosed
EP-2636666-A1 TRANS-2-DECENOIC ACID DERIVATIVE AND MEDICAMENT CONTAINING SAME Nagoya Industrial Science Research Institute (JP) 2013-09-11 EP disclosed
EP-2636666-A1 TRANS-2-DECENOIC ACID DERIVATIVE AND MEDICAMENT CONTAINING SAME Nagoya Industrial Science Research Institute (JP) 2013-09-11 EP disclosed
US-20130225837-A1 TRANS-2-DECENOIC ACID DERIVATIVE AND PHARMACEUTICAL AGENT CONTAINING THE SAME NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2013-08-29 US disclosed
US-20130225837-A1 TRANS-2-DECENOIC ACID DERIVATIVE AND PHARMACEUTICAL AGENT CONTAINING THE SAME NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2013-08-29 US disclosed
US-20130225837-A1 TRANS-2-DECENOIC ACID DERIVATIVE AND PHARMACEUTICAL AGENT CONTAINING THE SAME NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2013-08-29 US disclosed
CN-103189350-A Trans-2-decenoic acid derivative and drug containing same NAGOYA IND SCIENCE RES INST 2013-07-03 CN disclosed
WO-2012060396-A1 TRANS-2-DECENOIC ACID DERIVATIVE AND MEDICAMENT CONTAINING SAME 財団法人名古屋産業科学研究所 (JP) 2012-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150297562-A1 ANALGESIC OPRK1, OPRL1, OPRD1 ZDHHC20 1258/4885PPARG 1209/4885PPARA 757/4885
US-20130225837-A1 TRANS-2-DECENOIC ACID DERIVATIVE AND PHARMACEUTICAL AGENT CONTAINING THE SAME BDNF, NTRK2, NGF ZDHHC20 1090/4885PPARG 1310/4885PPARA 1112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.